Bendazac lysine inhibition of human lens epithelial cell adhesion to polymethylmethacrylate intraocular lenses

Ophthalmic Research

Volumn 36, Issue 3, 2004, Pages 145-150

  Soldo, Lucia ^a   Ruggieri, Alessandro ^a   Milanese, Claudio ^a   Pinza, Mario ^a   Guglielmotti, Angelo ^a  

^a ACRAF   (Italy)

Author keywords

Adhesiveness; Bendazac lysine; Lens epithelial cells; Polymethylmethacrylate intraocular lenses; Posterior capsule opacification; Secondary cataract

Indexed keywords

ANTIINFLAMMATORY AGENT; BENDAZAC; POLY(METHYL METHACRYLATE);

ARTICLE; CELL ADHESION; CELL COUNT; CELL LINE; DOSE RESPONSE; EPITHELIUM CELL; HUMAN; HUMAN CELL; INCUBATION TIME; LENS; LENS IMPLANT; PRIORITY JOURNAL;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL ADHESION; CELL LINE; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; HUMANS; INDAZOLES; LENS, CRYSTALLINE; LENSES, INTRAOCULAR; POLYMETHYL METHACRYLATE; TIME FACTORS;

EID: 2342568478     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000077327     Document Type: Article

References (40)

1. Kapphelof JP, Vresen GF: The pathology of after-cataract. A minireview. Acta Ophthalmol Suppl 1992;205:13-24.
2. Apple DJ, Solomon KD, Tetz MR: Posterior capsule opacification. Surv Ophthalmol 1992; 37:73-116.
3. Beasley AM, Auffarth GU, Von Recum AF: Intraocular lens implants: A biocompability review. J Invest Surg 1996;9:399-413.
4. Schaumberg DA, Dana MR, Christen WG, et al: A systematic overview of the incidence of posterior capsule opacification. Ophthalmology 1998;105:1213-1221.
5. Hollick EJ, Spalton DJ, Ursell PG, et al: Posterior capsular opacification with hydrogel, polymethylmethacrylate and silicone intraocular lenses: Two-year results of a randomized prospective trial. Am J Ophthalmol 2000;129: 577-584.
6. Scaramuzza A, Fernando GT, Crayford BB: Posterior capsular opacification with and lens epithelial cell layer formation: Hydroview hydrogel versus AcrySof acrylic intraocular lenses. J Cataract Refract Surg 2001;27:1047-1054.
7. Yamada K, Nagamoto T, Yozawa H, et al: Effect of intraocular lens design on posterior capsule opacification after continuous curvilinear capsulorhexis. J Cataract Refract Surg 1995;21:697-700.
8. McDonnell PJ, Rowen SL, Glaser BM, Sato M: Posterior capsule opacification. An in vitro model. Arch Ophthalmol 1985;103:1378-1381.
9. Grabner G, Zehetbauer G, Bettelheim H, et al: Immediate changes in protein-concentration in aqueous humor induced by intracapsular lens extraction in human eyes. Albrecht Von Graefes Arch Klin Exp Ophthalmol 1979;210: 275-289.
10. Latour E, Driot JY, Coquelet C, et al: The role of platelets in blood-aqueous barrier break-down induced by anterior chamber paracentesis in the rabbit. Curr Eye Res 1989;8:1105-1110.
11. Wolter JR: Cytopathology of intraocular lens implantation. Ophthalmology 1985;92:135-142.
12. Nishi O, Nishi K: Involvement of residual lens epithelial cells in postoperative inflammation after intraocular lens implantation - Cause of fibrin reaction. Asia Pac J Ophthalmol 1992;4: 2-6.
13. Schlotzer-Schrehardt U, Dorfler S: Immunolocalization of growth factors in the human ciliary body epithelium. Curr Eye Res 1993;12: 893-905.
14. 2 and leukocyte levels in aqueous humor after lens extraction and intraocular lens implantation. Ocul Immunol Inflamm 1993;1:151-157.
15. Versura P, Torreggiani A, Cellini M, et al: Adhesion mechanism of human lens epithelial cells on 4 intraocular lens materials. J Cataract Refract Surg 1999;25:527-533.
16. Silvestrini B, Cioli V, Burberi S: Pharmacological properties of bendazac (AF 983) with particular reference to its topical action on some experimental inflammatory processes. Arzneimittelforschung 1969;19:30-36.
17. Silvestrini B, Catanese B, Lisciani R, et al: Studies on the mechanism of action of bendazac (AF 983). Arzneimittelforschung 1970;20:250-253.
18. Catanese B, Rossi A, Silvestrini B, et al: Effect of bendazac and phenylbutazone on polymerization of bovine serum albumin. Pharmacol Res Commun 1976;8:549-555.
19. Schmut O, Hofmann H: Studies on the activity of bendaline (bendazac L-lysine salt) as a scavenger of hydroxyl and superoxide radicals. Wien Klin Wochenschr 1985;97:819-822.
20. Crabbe MJC, Hoe ST: Aldehyde deydrogenase, aldose reductase, and free radical scavengers in cataract. Enzyme 1991;45:188-193.
21. Guglielmotti A, Capezzone de Joannon A, Cazzolla N, et al: Radical scavenger activity of bendazac, an anticataract non-steroidal anti-inflammatory agent. Pharmacol Res 1995;32: 369-373.
22. Silvestrini B, Catanese B, Barillari G, et al: Basic data supporting the use of the L-lysine salt of bendazac in cataract. Int J Tissue React 1983;2:217-225.
23. Testa M, Iuliano G, Silvestrini B: Pilot study of bendazac for treatment of cataract. Lancet 1982;i:849-850.
24. Balfour JA, Clissold SP: Bendazac lysine. A review of its pharmacological properties and therapeutic potential in the management of cataracts. Drugs 1990;39:575-596.
25. Arciola CR, Montanaro l, Caramazza R, et al: Inhibition of bacterial adherence to a highwater-content polymer by water-soluble, nonsteroidal, anti-inflammatory drug. J Biomed Mater Res 1998;42:1-5.
26. Flick DA, Gifford GE: Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J Immunol Methods 1984;68:167-175.
27. Hayashi H, Hayashi K, Nakao F, Hayashi F: Quantitative comparison posterior capsule opacification after polymethylmethacrylate, silicone, and soft acrylic intraocular lens implantation. Arch Ophthalmol 1998;116:1579-1582.
28. Bath PE, Boerner CF, Dang Y: Pathology and physics of YAG-laser intraocular lens damage. J Cataract Refract Surg 1987;13:47-49.
29. Hansen SO, Apple DJ, Tetz MR, et al: Comparative histopathologic study of various lens biomaterials in primates after Nd:YAG laser treatment. J Cataract Refract Surg 1987;13: 657-661.
30. Schubert HD: Vitreoretinal changes associated with rise in intraocular pressure after Nd:YAG laser posterior capsulotomy. Ophthalmic Surg 1987;18:19-22.
31. Fourman S, Apisson J: Late-onset elevation in intraocular pressure after neodymium-YAG laser posterior capsulotomy. Arch Ophthalmol 1991;109:511-513.
32. Kraff MC, Sanders DR, Jampol LM, et al: Effect of primary capsulotomy with extracapsular surgery on the incidence of pseudophakic cystoid macular edema. Am J Ophthalmol 1984;98:166-170.
33. Ficker LA, Vickers S, Capon MR, et al: Retinal detachment following Nd:YAG laser posterior capsulotomy. Eye 1987;1:86-89.
34. Shah GR, Gills JP, Durham DG, et al: Three thousand YAG laser capsulotomies: An analysis of complications and comparison to polishing and surgical discission. Ophthalmic Surg 1986;17:473-477.
35. Lundgren B, Lundberg K, Tongren L, et al: Lack of correlation between intraocular inflammation and posterior capsular opacification (PCO) in the rabbit eye. Invest Ophthalmol Vis Sci 1996;37:S759.
36. Wallentin N, Lundberg C: Steroid and anti-CD18 treatment have no effect on after-cataract formation following surgery in rabbits. Curr Eye Res 2000;20:384-393.
37. Silvestrini B: Animal models for the study of atypical anti-inflammatory agents. Agents Actions 1985;17:329-337.
38. Cunanan CM, Tarbaux NM, Knight PM: Surface properties of intraocular lens materials and their influence on in vitro cell adhesion. J Cataract Refract Surg 1991;17:767-773.
39. Power WJ, Neylan D, Collum LM: Adherence of human lens epithelial cells to conventional poly(methylmethacrylate), heparin-surfacemodified, and polyHema lenses. J Cataract Refract Surg 1994;20:440-445.
40. De Gregorio F, Palmieri M, Ciarniello MG, Rosignoli MT, Dionisio P: A randomized double-masked placebo-controlled study of bendazac lysine eye drops in the prevention of posterior capsular opacification after cataract surgery. Boll Ocul 2002;81:1-9.